[HTML][HTML] Risk and protective factors for COVID-19 morbidity, severity, and mortality

J Zhang, X Dong, G Liu, Y Gao - Clinical reviews in allergy & immunology, 2023 - Springer
The outbreak of the coronavirus disease 2019 (COVID-19), caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become an evolving global …

[HTML][HTML] Cardiovascular complications of COVID-19

F Farshidfar, N Koleini, H Ardehali - JCI insight, 2021 - ncbi.nlm.nih.gov
The emergence of the novel SARS coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has …

Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial

A Gupta, Y Gonzalez-Rojas, E Juarez, MC Casal… - Jama, 2022 - jamanetwork.com
Importance Older patients and those with comorbidities who are infected with SARS-CoV-2
may be at increased risk of hospitalization and death. Sotrovimab is a neutralizing antibody …

Recent developments in the immunopathology of COVID‐19

H Zhang, Y Sun, Y Wang, D Yazici, D Azkur, I Ogulur… - Allergy, 2023 - Wiley Online Library
There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …

[HTML][HTML] Multisystem inflammatory syndrome in children and long COVID: the SARS-CoV-2 viral superantigen hypothesis

M Noval Rivas, RA Porritt, MH Cheng, I Bahar… - Frontiers in …, 2022 - frontiersin.org
Multisystem inflammatory syndrome in children (MIS-C) is a febrile pediatric inflammatory
disease that may develop weeks after initial SARS-CoV-2 infection or exposure. MIS-C …

Advances and highlights in biomarkers of allergic diseases

I Ogulur, Y Pat, O Ardicli, E Barletta, L Cevhertas… - Allergy, 2021 - Wiley Online Library
During the past years, there has been a global outbreak of allergic diseases, presenting a
considerable medical and socioeconomical burden. A large fraction of allergic diseases is …

[HTML][HTML] A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response

Y Zhao, L Sui, P Wu, W Wang, Z Wang, Y Yu… - … and Targeted Therapy, 2021 - nature.com
The recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is the causative agent of ongoing global pandemic of COVID-19, may trigger …

[HTML][HTML] Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis

ER Smith, E Oakley, GW Grandner, G Rukundo… - American journal of …, 2023 - Elsevier
Objective This sequential, prospective meta-analysis sought to identify risk factors among
pregnant and postpartum women with COVID-19 for adverse outcomes related to disease …

[HTML][HTML] Peer Reviewed: COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis

R Nagarajan, Y Krishnamoorthy, S Rajaa… - Preventing Chronic …, 2022 - ncbi.nlm.nih.gov
Methods We searched for studies reporting COVID-19 outcomes among CLD and non-CLD
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …

[HTML][HTML] COVID-19 and the vasculature: current aspects and long-term consequences

B Martínez-Salazar, M Holwerda, C Stüdle… - Frontiers in cell and …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …